Section Arrow
Quote
BMRA.NASDAQ
- Biomerica
Quotes are at least 15-min delayed:2026/01/22 13:32 EST
Regular Hours
Last
 2.55
+0.08 (+3.24%)
Day High 
2.59 
Prev. Close
2.47 
1-M High
2.935 
Volume 
17.18K 
Bid
2.56
Ask
2.58
Day Low
2.47 
Open
2.47 
1-M Low
2.31 
Market Cap 
7.46M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.68 
20-SMA 2.63 
50-SMA 2.48 
52-W High 8.8 
52-W Low 2.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.51/--
Enterprise Value
7.56M
Balance Sheet
Book Value Per Share
1.47
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.31M
Operating Revenue Per Share
1.79
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories109.92-10.81-8.95%15.3PE
DXCMDexCom75+2.89+4.01%39.94PE
PFSAProfusa Inc0.108-0.0066-5.76%-- 
PACBPacific Biosciences of California2.615+0.195+8.06%-- 
BSXBoston Scientific Corp92.38+0.67+0.73%49.04PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.